Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies

Annals of the New York Academy of Sciences

Volumn 825, Issue , 1997, Pages 194-205

  Scallet, Andrew C ^a   Ye, Xuemin ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; AMPHETAMINE; AMYLOID; ASPARTIC ACID; DOMOIC ACID; EXCITATORY AMINO ACID; EXCITATORY AMINO ACID RECEPTOR; GLUTAMIC ACID; IBOGAINE; N METHYL DEXTRO ASPARTIC ACID; TRIMETHYLTIN;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN SPONGIOSIS; CEREBELLUM; COMPARATIVE STUDY; CONFERENCE PAPER; CORPUS STRIATUM; DENDRITE; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; HYPOTHALAMUS; NEOCORTEX; NERVE DEGENERATION; NERVE FIBER; PARKINSON DISEASE; PERIKARYON; PRION DISEASE; PURKINJE CELL; PYRAMIDAL NERVE CELL;

ANIMALIA; CRICETINAE;

EID: 0030729807     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48429.x     Document Type: Conference Paper

References (96)

1. OLNEY, J. W. 1994. Excitotoxins in foods. Neurotoxicology 15: 535-544.
2. AUER, R. N. 1991. Excitotoxic mechanisms, and age-related susceptibility to brain damage in ischemia, hypoglycemia and toxic mussel poisoning. Neurotoxicology 12: 541-546.
3. ROSS, D. T., D. I. GRAHAM, & J. H. ADAMS. 1993. Selective loss of neurons from the thalamic reticular neurons following severe human head injury. J. Neurotrauma 10: 151-165.
4. SPENCER, P. S., A. C. LUDOLPH & G. E. KISBY. 1992. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties? [Review]. Ann. N. Y. Acad. Sci. 648: 154-160.
5. TURSKI, L. & W. A. TURSKI. 1993. Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology [Review]. Experientia 49: 1064-1072.
6. OLNEY, J. W. & M. T. PRICE. 1981. Neuroendocrine effects of excitotoxic amino acids [Review]. Adv. Biochem. Psychopharmacol. 27: 423-432.
7. VERDOORN, T. A. & R. DINGLEDINE. 1988. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Mol. Pharmacol. 34: 298-307.
8. KAMBOJ, R. K., D. D. SCHOEPP, S. NUTT, L. SHEKTER, B. KORCZAK, R. A. TRUE, D. M. ZIMMERMAN & M. A. WOSNICK. 1992. Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit. Mol. Pharmacol. 42: 10-15.
9. KAMBOJ, R. K., D. D. SCHOEPP, S. NUTT, L. SHEKTER, B. KORCZAK, R. A. TRUE, V. RAMPERSAD, D. M. ZIMMERMAN & M. A. WOSNICK. 1994. Molecular cloning, expression, and pharmacological characterization of humEAA1, a human kainate receptor subunit. J. Neurochem. 62: 1-9.
10. LOMELI, H., W. WISDEN, M. KOHLER, K. KEINANEN, B. SOMMER & P. H. SEEBURG. 1992. High-affinity kainate and domoate receptors in rat brain. FEBS Lett. 307: 139-143.
11. SLADECZEK, F., O. MANZONI, L. FAGNI, A. DUMUIS, J. P. PIN, M. SEBBEN & J. BOCKAERT. 1992. The metabotropic glutamate receptor (MGR): pharmacology and subcellular location. J. Physiol. (Paris) 86: 47-55.
12. SUN, W., A. V. FERRER-MONTIEL, A. F. SCHINDER, J. P. MCPHERSON, G. A. EVANS & M. MONTAL. 1992. Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors. Proc. Natl. Acad. Sci. USA 89: 1443-1447.
13. BEAL, M. F. 1994. Neurochemistry and toxin models in Huntington's disease [Review]. Curr. Opin. Neurol. 7: 542-547.
14. 3H]kainate binding sites in human hippocampus. Neurosci. Lett. 187: 107-110.
15. TILSON, H. A. & W. R. MUNDY. 1995. Bases of excitatory amino acid system-related neurotoxicity. In Neurotoxicology: Approaches and Methods. L. W. Chang & W. Slikker, Jr., Eds. 359-370. Academic Press. San Diego, CA.
16. HAMPSON, D. R., X. P. HUANG, M. D. OBERDORFER, J. W. GOH, A. AUYEUNG & R. J. WENTHOLD. 1992. Localization of AMPA receptors in the hippocampus and cerebellum of the rat using an anti-receptor monoclonal antibody. Neuroscience 50: 11-22.
17. MANZONI, O. J., F. POULAT, E. DO, A. SAHUQUET, I. SASSETTI, J. BOCKAERT & F. A. SLADECZEK. 1991. Pharmacological characterization of the quisqualate receptor coupled to phospholipase C (Qp) in striatal neurons. Eur. J. Pharmacol. 207: 231-241.
18. MONTGOMERY, D. L. 1994. Astrocytes: form, functions, and roles in disease [Review]. Vet. Pathol. 31: 145-167.
19. ENG, L. F. & R. S. GHIRNIKAR. 1994. GFAP and astrogliosis [Review]. Brain Pathol. 4: 229-237.
20. SCALLET, A. C. & J. W. OLNEY. 1986. Components of hypothalamic obesity: bipiperidylmustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Res. 374: 380-384.
21. OLNEY, J. W. 1969. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721.
22. OLNEY, J. W., M. T. PRICE, L. SAMSON & J. LABRUYERE. 1986. The role of specific ions in glutamate neurotoxicity. Neurosci. Lett. 65: 65-71.
23. ROTHMAN, S. M. & J. W. OLNEY. 1995. Excitotoxicity and the NMDA receptor - still lethal after eight years [Review]. Trends Neurosci. 18: 57-58.
24. THOMPSON, M. C., N. S. NORTON, J. F. RODRIGUEZ-SIERRA & L. LIPPIELLO. 1994. Is glutamate-induced reduction in growth hormone-releasing a neuroendocrine model of aging in the rat? Proc. Soc. Exp. Biol. Med. 206: 69-75.
25. WAKABAYASHI, I., H. HATANO, S. MINAMI, Y. TONEGAWA, S. AKIRA, H. SUGIHARA & N. C. LING. 1986. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats. Brain Res. 372: 361-365.
26. BLOCH, B., N. LING, R. BENOIT, W. B. WEHRENBERG & R. GUILLEMIN. 1984. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature 307: 272-273.
27. MILLARD, W. J., J. B. MARTIN, JR., J. AUDET, S. M. SAGAR & J. B. MARTIN. 1982. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110: 540-550.
28. MAGARINOS, A. M., F. ESTIVARIZ, M. I. MORADO & A. F. DE NICOLA. 1988. Regulation of the central nervous system-pituitary-adrenal axis in rats after neonatal treatment with monosodium glutamate. Neuroendocrinology 48: 105-111.
29. ROSE, P. A. & R. F. WEICK. 1986. Effects of anterior hypothalamic deafferentiation and neonatal monosodium-L-glutamate treatment on pulsatile LH secretion in the castrated rat. Neuroendocrinology 43: 12-17.
30. ACS, Z., F. A. ANTONI & G. B. MAKARA. 1982. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate. J. Endocrinol. 93: 239-245.
31. DADA, M. O. & C. A. BLAKE. 1984. Administration of monosodium glutamate to neonatal male rats: alterations in the gonadotrophs and in gonadotrophin secretion. Neuroendocrinology 38: 490-497.
32. DADA, M. O., J. F. RODRIGUEZ-SIERRA, R. W. CLOUGH, L. L. GARNER & C. A. BLAKE. 1985. Monosodium glutamate and pituitary gland luteinizing hormone (LH) release in response to LH-releasing hormone: an in vitro study. Endocrinology 116: 246-251.
33. DYER, R. G., R. F. WEICK, S. MANSFIELD & H. CORBET. 1981. Secretion of luteinizing hormone in ovariectomized adult rats treated neonatally with monosodium glutamate. J. Endocrinol. 91: 341-346.
34. JOHNSTON, C. A., M. TESONE & A. NECRO-VILAR. 1984. Steroid-monoamine feedback interactions in discrete brain regions using as a model the monosodium glutamate (MSG)-lesioned rat. Life Sci. 34: 1287-1297.
35. JOHNSTON, C. A., E. J. SPINEDI & A. NEGRO-VILAR. 1984. Effects of neonatal monosodium glutamate (MSG) treatment on the hormonal and central monoaminergic dynamics associated with acute ether stress in the male rat. Brain Res. Bull. 13: 643-649.
36. MIZUNUMA, H., O. KHORRAM & S. M. MCCANN. 1983. Blockade of stress-induced prolactin release in monosodium glutamate-treated rats. Brain Res. Bull. 10: 23-26.
37. NEMEROFF, C. B., C. A. LAMARTINIERE, G. A. MASON, R. E. SQUIBB, J. S. HONG & S. C. BONDY. 1981. Marked reduction in gonadal steroid hormone levels in rats treated neonatally with monosodium-L-glutamate: further evidence for disruption of hypothalamic-pituitary-gonadal axis regulation. Neuroendocrinology 33: 265-267.
38. SAPHIER, D. J. & R. G. DYER. 1981. Effects of neonatal exposure to monosodium glutamate on the electrical activity of neurones in the mediobasal hypothalamus, and on the plasma concentrations of thyroid-stimulating hormone and prolactin, following stimulation of the rostral hypothalamus in adult female rats. J. Endocrinol. 89:379-387.
39. TERRY, L. C., J. EPELBAUM & J. B. MARTIN. 1981. Monosodium glutamate: acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat. Brain Res. 217: 129-142.
40. BODNAR, R. J., G. M. ABRAMS, E. A. ZIMMERMAN, D. T. KRIEGER, G. NICHOLSON & J. S. KIZER. 1980. Neonatal monosodium glutamate. Effects upon analgesic responsivity and immunocytochemical ACTH/beta-lipotropin. Neuroendocrinology 30: 280-284.
41. RODRIGUEZ-SIERRA, J. F., J. D. BLAUSTEIN, C. A. BLAKE, R. W. CLOUGH & K. A. ELIAS. 1982. A decrease of cytosol estrogen receptors in the hypothalamus as a result of treatment of neonatal rats with glutamate. Exp. Brain Res. 48: 272-278.
42. ALESSI, N. E., P. QUINLAN & H. KHACHATURIAN. 1988. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla. Peptides 9: 689-695.
43. DALKIN, A. C., J. A. DUNCAN, S. REGIANI & J. C. MARSHALL. 1985. Reduction of pituitary GnRH receptors in immature rats treated with monosodium glutamate. Am. J. Physiol. 248 (Pt. 1): E126-E131.
44. INKSTER, S. E., R. N. CLAYTON & S. A. WHITEHEAD. 1985. Pituitary receptors for LH-releasing hormone (LHRH) and responsiveness to LHRH in adult female rats after neonatal monosodium-L-glutamate treatment. J. Endocrinol. 107: 9-13.
45. BLAKE, C. A., D. A. CROUSE, M. O. DADA, J. F. RODRIGUEZ-SIERRA & J. G. SHARP. 1984. A decrease in thymus-mediated immune responses as a result of treatment of neonatal rats with glutamate. Life Sci. 35: 789-795.
46. TANAKA, K., M. SHIMADA, A. SASAHARA, N. OYA, Y. FUJIYAMA & S. HOSODA. 1983. Neonatal monosodium glutamate-induced lesions of hypothalamus increase intestinal fat absorption in adult mice. Exp. Neurol. 79: 141-151.
47. SARTIN, J. L., A. A. LAMPERTI & R. J. KEMPPAINEN. 1985. Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus. Endocr. Res. 11: 145-155.
48. CENDES, F., F. ANDERMANN, S. CARPENTER, R. J. ZATORRE & N. R. CASHMAN. 1995. Temporal lobe epilepsy caused by domoic acid intoxication - evidence for glutamate receptor-mediated excitotoxicity in humans. Ann. Neurol. 37: 123-126.
49. GJEDDE, A., & A. C. EVANS. 1990. PET studies of domoic acid poisoning in humans: excitotoxic destruction of brain glutamatergic pathways, revealed in measurements of glucose metabolism by positron emission tomography. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 105-109.
50. PERL, T. M., L. BEDARD, T. KOSATSKY, J. C. HOCKIN, E. C. TODD & R. S. REMIS. 1990. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid [see comments]. N. Engl. J. Med. 322: 1775-1780.
51. PERL, T. M., L. BEDARD, T. KOSATSKY, J. C. HOCKIN, E. C. TODD, L. A. MCNUTT & R. S. REMIS. 1990. Amnesic shellfish poisoning: a new clinical syndrome due to domoic acid. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 7-8.
52. PERL, T. M., J. TEITELBAUM, J. HOCKIN & E. C. TODD. 1990. Domoic acid toxicity. Panel discussion: definition of the syndrome. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 41-45.
53. TEITELBAUM, J., R. J. ZATORRE, S. CARPENTER, D. GENDRON & N. R. CASHMAN. 1990. Neurological sequelae of domoic acid intoxication. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 9-12.
54. TEITELBAUM, J. S., R. J. ZATORRE, S. CARPENTER, D. GENDRON, A. C. EVANS, A. GJEDDE & N. R. CASHMAN. 1990. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated muscle [see comments]. N. Engl. J. Med. 322: 1781-1787.
55. ZATORRE, R. J. 1990. Memory loss following domoic acid intoxication from ingestion of toxic mussels. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 101-103.
56. DEBONNEL, G., M. WEISS & C. DE MONTIGNY. 1989. Reduced neuroexcitatory effect of domoic acid following mossy fiber denervation of the rat dorsal hippocampus: further evidence that toxicity of domoic acid involves a kainate receptor activation. Can. J. Physiol. Pharmacol. 67: 904-908.
57. DEBONNEL, G., L. BEAUCHESNE & C. DE MONTIGNY. 1989. Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in the dorsal hippocampus. Can. J. Physiol. Pharmacol. 67: 29-33.
58. DEBONNEL, G., M. WEISS & C. DE MONTIGNY. 1990. Neurotoxic effect of domoic acid: metabolism by kainate receptor electrophysiological studies in the rat. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 59-68.
59. STEWART, G. R., C. F. ZORUMSKI, M. T. PRICE & J. W. OLNEY. 1990. Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity. Exp. Neurol. 110: 127-138.
60. ROBERTSON, H., K. RENTON, J. KOHN & T. WHITE. 1992. Patterns of Fos expression suggest similar mechanisms of action for the excitotoxins domoic and kainic acid. Ann. N. Y. Acad. Sci. 648: 330-334.
61. SCALLET, A. C., Z. BINIENDA, F. A. CAPUTO, S. HALL, M. G. PAULE, R. L. ROUNTREE, L. SCHMUED, T. SOBOTKA & W. SLIKKER, JR. 1993. Domoic acid-treated cynomolgus monkeys (M. fascicularis): effects of dose on hippocampal neuronal and terminal degeneration. Brain Res. 627: 307-313.
62. STEWART, G. R., J. W. OLNEY, M. PATHIKONDA & W. D. SNIDER. 1991. Excitotoxicity in the embryonic chick spinal cord. Ann. Neurol. 30: 758-766.
63. TERRIAN, D. M., T. A. CONNER-KERR, T. H. PRIVETTE & R. L. GANNON. 1991. Domoic acid enhances the K(+)-evoked release of endogenous glutamate from guinea pig hippocampal mossy fiber synaptosomes. Brain Res. 551: 303-307.
64. BOSE, R., C. PINSKY & G. B. GLAVIN. 1990. Sensitive murine model and putative antidotes for behavioral toxicosis from contaminated mussel extracts. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 91-98.
65. GLAVIN, G., C. PINSKY & R. BOSE. 1989. Toxicology of mussels contaminated by neuroex-citant domoic acid [letter]. Lancet 1: 506-507.
66. GLAVIN, G. B., C. PINKSY & R. BOSE. 1989. Toxicology of mussels contaminated by neuroexcitant domoic acid [letter]. Lancet 1: 506-507.
67. GLAVIN, G. B., C. PINSKY & R. BOSE. 1990. Domoic acid-induced neurovisceral toxic syndrome: characterization of an animal model and putative antidotes. Brain Res. Bull. 24: 701-703.
68. IVERSON, F., J. TRUELOVE, E. NERA, L. TRYPHONAS, J. CAMPBELL & E. LOK. 1989. Domoic acid poisoning and mussel-associated intoxication: preliminary investigations into the response of mice and rats to toxic mussel extract. Food Chem. Toxicol. 27: 377-384.
69. SUTHERLAND, R. J., J. M. HOESING & I. Q. WHISHAW. 1990. Domoic acid, an environmental toxin, produces hippocampal damage and severe memory impairment. Neurosci. Lett. 120: 221-223.
70. TRYPHONAS, L., J. TRUELOVE & F. IVERSON. 1990. Acute parenteral neurotoxicity of domoic acid in cynomolgus monkeys (M. fascicularis) [published erratum appears in Toxicol. Pathol. 1990; 18(3):431]. Toxicol. Pathol. 18: 297-303.
71. TRYPHONAS, L. & F. IVERSON. 1990. Neuropathology of excitatory neurotoxins: the domoic acid model [Review]. Toxicol. Pathol. 18 (Pt. 2): 165-169.
72. TRYPHONAS, L., J. TRUELOVE, E. NERA & F. IVERSON. 1990. Acute neurotoxicity of domoic acid in the rat. Toxicol. Pathol. 18 (Pt. 1): 1-9.
73. TRYPHONAS, L., J. TRUELOVE, E. TODD, E. NERA & F. IVERSON. 1990. Experimental oral toxicity of domoic acid in cynomolgus monkeys (Macaca fascicularis) and rats. Preliminary investigations. Food & Chem. Toxicol. 28: 707-715.
74. BRUNI, J. E., R. BOSE, C. PINSKY & G. GLAVIN. 1991. Circumventricular organ origin of domoic acid-induced neuropathology and toxicology. Brain Res. Bull. 26: 419-424.
75. STRAIN, S. M. & R. A. TASKER. 1991. Hippocampal damage produced by systemic injections of domoic acid in mice. Neuroscience 44: 343-352.
76. 74a. SOBOTKA, T. J., R. BROWN, D. Y. QUANDER, R. JACKSON, M. SMITH, S. A. LONG, C. N. BARTON, R. L. ROUNTREE, S. HALL, P. EILERS, J. N. JOHANNESSEN & A. C. SCALLET. 1996. Domoic acid: neurobehavioral and neurohistological effects of low-dose exposure in adult rats. Neurotoxicol. Teratol. 18: 659-670.
77. SHEPPARD, S. G. 1994. A preliminary investigation of ibogaine: case reports and recommendations for further study. J. Subst. Abuse Treat. 11: 379-385.
78. DEECHER, D. C., M. TEITLER, D. M. SODERLUND, W. G. BORNMANN, M. E. KUEHNE & S. D. GLICK. 1992. Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding sites. Brain Res. 571: 242-247.
79. 3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology 114: 672-674.
80. MASH, D. C., J. K. STALEY, J. P. PABLO, A. M. HOLOHEAN, J. C. HACKMAN & R. A. DAVIDOFF. 1995. Properties of ibogaine and its principal metabolite (12-hydroxy-ibogamine) at the MK-801 binding site of the NMDA receptor complex. Neurosci. Lett. 192: 53-56.
81. POPIK, P., R. T. LAYER & P. SKOLNIK. 1995. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacol. Rev. 47: 235-253.
82. O'HEARN, E. & M. E. MOLLIVER. 1993. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55: 303-310.
83. O'HEARN, E., D. B. LONG & M. E. MOLLIVER. 1993. Ibogaine induces glial activation in parasagittal zones of the cerebellum. NeuroReport 4: 299-302.
84. 81a. SCALLET, A. C., X. YE, R. L. ROUNTREE, P. NONY & S. F. ALI. 1996. Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Ann. N. Y. Acad. Sci. 801: 217-226.
85. YE, X. A. & R. I. CARP. 1994. Astrocytosis and proliferating cell nuclear antigen (PCNA) expression in brain of scrapie-infected animals. Soc. Neurosci. Abstr. 20: 1258.
86. TEITELBAUM, J. 1990. Acute manifestations of domoic acid poisoning: case presentations. Can. Dis. Weekly Rep. 16 (Suppl. 1E): 5-6.
87. YE, X., R. I. CARP, Y. YU, R. KOZIELSKI & P. KOZLOWSKI. 1994. Hyperplasia and hypertrophy of B cells in the islets of Langerhans in hamsters infected with the 139H strain of scrapie. J. Comp. Pathol. 110: 169-183.
88. YE, X., R. I. CARP, & R. J. KASCSAK. 1994. Histopathological changes in the islets of Langerhans in scrapie 139H-affected hamsters. J. Comp. Path. 110: 153-167.
89. CARP, R. I., X. YE, R. J. KASCSAK, R. RUBENSTEIN. 1994. The nature of the scrapie agent. Biological characteristics of scrapie in different scrapie strain-host combinations [Review]. Ann. N. Y. Acad. Sci. 724: 221-234.
90. VAN HOLTEN, M., B. I. POSNER, B. M. KOPRIWA & J. R. BRAWER. 1980. Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science 207: 1081-1083.
91. VAN HOUTEN, M. & B. I. POSNER. 1981. Cellular basis of direct insulin action in the central nervous system [Review]. Diabetologia 20: Suppl: 255-267.
92. HUNTER, A. J., M. P. CAULFIELD & R. H. KIMBERLIN. 1986. Learning ability of mice infected with different strains of scrapie. Physiol. Behav. 36: 1089-1092.
93. MCFARLAND, D., & J. HOTCHIN. 1980. Early behavioral abnormalities in mice due to scrapie virus encephalopathy. Biol. Psychiatry 15: 37-44.
94. GIESE, A., M. H. GROSCHUP, B. HESS & H. A. KRETZSCHMAR. 1995. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol. 5: 213-221.
95. GUIROY, D. C., I. WAKAYAMA, P. P. LIBERSKI & D. C. GAJDUSEK. 1994. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome. Acta Neuropathol. 87: 526-530.
96. WILL, R. G., J. W. IRONSIDE, M. ZEIDLER, S. N. COUSENS, K. ESTIBEIRO, A. ALPEROVITCH, S. POSER, M. POCCHIARI, A. HOFMAN & P. G. SMITH. 1996. A new variant of Creutzfelt-Jakob disease in the UK [see comments]. Lancet 347: 921-925.